comparemela.com

Latest Breaking News On - மருந்து சூத்திரங்கள் - Page 2 : comparemela.com

Unichem Labs gets USFDA approval for Guanfacine tablets

Unichem Laboratories announced that it has received ANDA approval for its Guanfacine Tablets from the USFDA to market a generic version of TENEX (Guanfacine) tablets. Unichem Laboratories announced that it has received ANDA approval for its Guanfacine Tablets, USP 1 mg and 2 mg from the United States Food and Drug Administration (USFDA) to market a generic version of TENEX (Guanfacine) Tablets 1mg and 2 mg of Promius Pharma LLC. Guanfacine Tablets are indicated in the management of hypertension. The product will be commercialized from Unichem s Ghaziabad Plant. The announcement was made after market hours yesterday, 4 March 2021. Shares of Unichem Laboratories rose 2.66% to settle at Rs 343.50 yesterday.

United-states
India
Drug-administration
Promius-pharma
Unichem-laboratories
Guanfacine-tablets
United-states-food
Capital-market
Guanfacine
Health-care
Health

Unichem Labs spurts on USFDA nod for psoriasis drug

Unichem Laboratories surged 5.71% to Rs 323.05 after the company received United States Food and Drug Administration (USFDA) approval for apremilast tablets, 10 mg, 20 mg and 30 mg. The drug is a generic version of Amgen s Otezla (apremilast) tablets, 10 mg, 20 mg, and 30 mg. The drug is indicated for the treatment of adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy. The scrip extended gains for third day. The stock has added 6.67% in three sessions from its recent closing low of Rs 302.85 recorded on 16 February 2021. In the past three months, the stock has added 36.73% while the benchmark Sensex has added 17.55% during the same period.

United-states
Amgen-otezla
Drug-administration
Unichem-laboratories
United-states-food
Capital-market
Drugs
Branches-of-biology
Apremilast
Mg-cars
Medroxyprogesterone-acetate
Magnesium-in-biology

Modified Wheat Starch Market (Covid-19 Analysis) SWOT Analysis, Key Indicators, Forecast 2028 | Tereos Group, Cargill, KRONER-STARKE, AGRANA, Grain processing Corporation, ADM, and more – KSU

2 According to Zeal Insider, the Modified Wheat Starch market is estimated to rise at US$ xx million in 2028 at a CAGR of xx% throughout the forecast period from 2020 to 2028. The Modified Wheat Starch market research report covers detailed information about market definitions and its classification, along with, global segmentation for Modified Wheat Starch market, product overview, industry outline, raw material and cost structure. In addition, the research report offers critical analysis of market dynamics, detailed study of key regional trends, and further delivers country-level market scope and revenue of the Modified Wheat Starch Industry. Moreover, the Modified Wheat Starch market report embraces industry regulatory policies, drivers, restrains, opportunities, and challenges, which helps manufacturers to take their strategic decisions. The report includes current as well as forecast data for the period from 2020 to 2028, and also provides compounded annual growth rate (CAGR%

Japan
United-states
United-kingdom
Argentina
Brazil
China
South-africa
Canada
Russia
Mexico
Germany
India

Organo-Modified Siloxanes Market 2020 Financial Information, Developments and SWOT Analysis by Global Forecast 2025

Organo-Modified Siloxanes Market 2020 Financial Information, Developments and SWOT Analysis by Global Forecast 2025
newyorktelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newyorktelegraph.com Daily Mail and Mail on Sunday newspapers.

Japan
United-kingdom
Argentina
Brazil
China
South-africa
Canada
Russia
Mexico
Germany
India
Nigeria
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.